ALS limited Produced Strong results for H1FY19; Revenue up by 11.3%

  • Nov 20, 2019 AEDT
  • Team Kalkine

ALS Limited (ASX: ALQ) is pleased to announce the half-yearly results for the period ended 30 September 2019, Few highlights from the results are as follows:

  • The company reported revenue from continuing operations of $919.1 million, up by 11.3% compared to the previous corresponding period (pcp).
  • The Underlying NPAT from continuing operations has been increased by 5.3 per cent to $98.2 million, exceeding guidance of $90 million - $95 million.
  • ALS Reported Life Sciences organic revenue growth of 10.2% and Industrial organic revenue growth of 20.3%.
  • Underlying basic earnings per share (eps) of 20.3 cents per share (cps), up by 6.3% from PCP.
  • The company has declared Interim Dividend of 11.5 cents per share, partially franked to 30%.
  • ALS expected NPAT to remain in between $185 million to $195 million.
  • Statutory NPAT of $135.6 million, up $50.7 million due to one-off gains.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK